Date Founded



10188 Telesis Court,Suite 100,San Diego, CA 92121-4779

Type of Company


Employees (Worldwide)

501 - 1,000


Computer Software
Other Business & Consulting Services

Company Description

Accelrys (NASDAQ:ACCL), a leading provider of scientific innovation lifecycle management software, supports industries and organizations that rely on scientific innovation to differentiate themselves. The industry-leading Accelrys Enterprise Platform provides a broad, flexible scientific solution optimized to integrate the diversity of science, experimental processes and information requirements across the research, development, process scale-up and early manufacturing phases of product development. By incorporating capabilities in applications for modeling and simulation, enterprise lab management, workflow and automation, and data management and informatics, Accelrys enables scientific innovators to access, organize, analyze and share data in unprecedented ways, ultimately enhancing innovation, improving productivity and compliance, reducing costs and speeding time from lab to market.

Contact Data
Trying to get in touch with decision makers at BIOVIA, Inc.? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Executives & Employees

Chief Executive Officer

Chief Financial Officer & Senior Vice President, Operations

Senior Vice President & Chief Technology Officer

Senior Vice President, Software Development

Senior Vice President-Marketing & Product Management

Senior Vice President, Global Field Operations

Senior Director



Paths to BIOVIA, Inc.
Potential Connections via
Relationship Science
Recent Transactions
Details Hidden

Dassault Systèmes SA purchases BIOVIA, Inc.

Details Hidden

BIOVIA, Inc. purchases QUMAS Ltd. from Eight Roads Capital Advisors (UK) Ltd.

Details Hidden

BIOVIA, Inc. purchases ChemSW, Inc.

Transaction Advisors
Legal Advisor

Advised onDassault Systèmes SA purchases BIOVIA, Inc.


Advised onBIOVIA, Inc. purchases Molecular Simulations, Inc.

Legal Advisor

Advised onTakeda Oncology Co. purchases Cambridge Discovery Chemistry from BIOVIA, Inc.

Legal Advisor

Advised onDassault Systèmes SA purchases BIOVIA, Inc.

Chair of San Diego Office

Advised onDassault Systèmes SA purchases BIOVIA, Inc.


Advised onDassault Systèmes SA purchases BIOVIA, Inc.

Key Stats and Financials As of
Market Capitalization
Total Enterprise Value
Earnings Per Share
Details Hidden

Intermolecular, Inc. engages in the provision of solutions for the evaluation and development of engineered thin-film materials for next-generation technology products. It offers platform and multi-disciplinary development team for the research and development of advanced materials in the semiconductor, displays, and glass and coatings industries. The company was founded by David E. Lazovsky in June 2004 and is headquartered in San Jose, CA.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by BIOVIA, Inc.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of BIOVIA, Inc.'s profile does not indicate a business or promotional relationship of any kind between RelSci and BIOVIA, Inc..